Interleukin-19 Mediates Tissue Damage in Murine Ischemic Acute Kidney Injury

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Hsu, Yu Hsiang ^a   Li, Hsing Hui ^b   Sung, Junne Ming ^a   Chen, Wei Ting ^a   Hou, Ya Chin ^a   Chang, Ming Shi ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL MUSEUM OF MARINE BIOLOGY AND AQUARIUM   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; INTERLEUKIN 10; INTERLEUKIN 19; INTERLEUKIN 1BETA; INTERLEUKIN 20; INTERLEUKIN 20R1; INTERLEUKIN DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANATOMICAL VARIATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; KIDNEY ISCHEMIA; KIDNEY TUBULE EPITHELIUM; LIVER INJURY; LUNG INJURY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL; WILD TYPE;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; CASPASES; CELL DEATH; CELL LINE; CHEMOKINE CCL2; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; INTERLEUKIN-10; LIVER; MALE; MICE; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTORS, INTERLEUKIN; REPERFUSION INJURY; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84874485590     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056028     Document Type: Article

References (43)

1. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR, (2009) Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 53: 961-973.
2. Rana A, Sathyanarayana P, Lieberthal W, (2001) Role of apoptosis of renal tubular cells in acute renal failure: therapeutic implications. Apoptosis 6: 83-102.
3. Akcay A, Nguyen Q, Edelstein CL, (2009) Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009: 137072.
4. Devarajan P, (2006) Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17: 1503-1520.
5. Deng J, Kohda Y, Chiao H, Wang Y, Hu X, et al. (2001) Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int 60: 2118-2128.
6. Kelly KJ, (2003) Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 14: 1549-1558.
7. Kramer AA, Postler G, Salhab KF, Mendez C, Carey LC, et al. (1999) Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int 55: 2362-2367.
8. Hoke TS, Douglas IS, Klein CL, He Z, Fang W, et al. (2007) Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J Am Soc Nephrol 18: 155-164.
9. Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, et al. (2000) Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 1: 442-450.
10. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, et al. (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22: 929-979.
11. Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC, (2001) Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 167: 3545-3549.
12. Liao YC, Liang WG, Chen FW, Hsu JH, Yang JJ, et al. (2002) IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J Immunol 169: 4288-4297.
13. Hsing CH, Hsieh MY, Chen WY, Cheung So E, Cheng BC, et al. (2006) Induction of interleukin-19 and interleukin-22 after cardiac surgery with cardiopulmonary bypass. Ann Thorac Surg 81: 2196-2201.
14. Hsing CH, Chiu CJ, Chang LY, Hsu CC, Chang MS, (2008) IL-19 is involved in the pathogenesis of endotoxic shock. Shock 29: 7-15.
15. Liao SC, Cheng YC, Wang YC, Wang CW, Yang SM, et al. (2004) IL-19 induced Th2 cytokines and was up-regulated in asthma patients. J Immunol 173: 6712-6718.
16. Okusa MD, (2002) The inflammatory cascade in acute ischemic renal failure. Nephron 90: 133-138.
17. Pecoits-Filho R, Sylvestre LC, Stenvinkel P, (2005) Chronic kidney disease and inflammation in pediatric patients: from bench to playground. Pediatr Nephrol 20: 714-720.
18. Lee DW, Faubel S, Edelstein CL, (2011) Cytokines in acute kidney injury (AKI). Clin Nephrol 76: 165-173.
19. Jordan WJ, Eskdale J, Boniotto M, Lennon GP, Peat J, et al. (2005) Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10. Eur J Immunol 35: 1576-1582.
20. Wong VY, Keller PM, Nuttall ME, Kikly K, DeWolf WE Jr, et al. (2001) Role of caspases in human renal proximal tubular epithelial cell apoptosis. Eur J Pharmacol 433: 135-140.
21. Golab F, Kadkhodaee M, Zahmatkesh M, Hedayati M, Arab H, et al. (2009) Ischemic and non-ischemic acute kidney injury cause hepatic damage. Kidney Int 75: 783-792.
22. Serteser M, Koken T, Kahraman A, Yilmaz K, Akbulut G, et al. (2002) Changes in hepatic TNF-alpha levels, antioxidant status, and oxidation products after renal ischemia/reperfusion injury in mice. J Surg Res 107: 234-240.
23. Saperstein S, Chen L, Oakes D, Pryhuber G, Finkelstein J, (2009) IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cells. J Interferon Cytokine Res 29: 273-284.
24. Hsu YH, Chen WY, Chan CH, Wu CH, Sun ZJ, et al. (2011) Anti-IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss. J Exp Med 208: 1849-1861.
25. Li HH, Lin YC, Chen PJ, Hsiao CH, Lee JY, et al. (2005) Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis. Br J Dermatol 153: 591-595.
26. Dai C, Yang J, Liu Y, (2003) Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling. J Biol Chem 278: 12537-12545.
27. Hay ED, Zuk A, (1995) Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 26: 678-690.
28. Franke TF, Kaplan DR, Cantley LC, (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88: 435-437.
29. Wang X, Shaw S, Amiri F, Eaton DC, Marrero MB, (2002) Inhibition of the Jak/STAT signaling pathway prevents the high glucose-induced increase in tgf-beta and fibronectin synthesis in mesangial cells. Diabetes 51: 3505-3509.
30. Amiri F, Shaw S, Wang X, Tang J, Waller JL, et al. (2002) Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int 61: 1605-1616.
31. Kim YK, Kim HJ, Kwon CH, Kim JH, Woo JS, et al. (2005) Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. J Appl Toxicol 25: 374-382.
32. Zhuang S, Yan Y, Daubert RA, Han J, Schnellmann RG, (2007) ERK promotes hydrogen peroxide-induced apoptosis through caspase-3 activation and inhibition of Akt in renal epithelial cells. Am J Physiol Renal Physiol 292: F440-447.
33. Kunduzova OR, Bianchi P, Pizzinat N, Escourrou G, Seguelas MH, et al. (2002) Regulation of JNK/ERK activation, cell apoptosis, and tissue regeneration by monoamine oxidases after renal ischemia-reperfusion. Faseb J 16: 1129-1131.
34. Nguyen HT, Hsieh MH, Gaborro A, Tinloy B, Phillips C, et al. (2006) JNK/SAPK and p38 SAPK-2 mediate mechanical stretch-induced apoptosis via caspase-3 and-9 in NRK-52E renal epithelial cells. Nephron Exp Nephrol 102: e49-61.
35. Yadav N, Rao S, Bhowmik DM, Mukhopadhyay A, (2012) Bone marrow cells contribute to tubular epithelium regeneration following acute kidney injury induced by mercuric chloride. Indian J Med Res 136: 211-220.
36. Jiang J, Dean D, Burghardt RC, Parrish AR, (2004) Disruption of cadherin/catenin expression, localization, and interactions during HgCl2-induced nephrotoxicity. Toxicol Sci 80: 170-182.
37. Rabb H, Wang Z, Nemoto T, Hotchkiss J, Yokota N, et al. (2003) Acute renal failure leads to dysregulation of lung salt and water channels. Kidney Int 63: 600-606.
38. Deng J, Hu X, Yuen PS, Star RA, (2004) Alpha-melanocyte-stimulating hormone inhibits lung injury after renal ischemia/reperfusion. Am J Respir Crit Care Med 169: 749-756.
39. Li HH, Hsu YH, Wei CC, Lee PT, Chen WC, et al. (2008) Interleukin-20 induced cell death in renal epithelial cells and was associated with acute renal failure. Genes Immun 9: 395-404.
40. Wei CC, Li HH, Hsu YH, Hsing CH, Sung JM, et al. (2008) Interleukin-20 targets renal cells and is associated with chronic kidney disease. Biochem Biophys Res Commun 374: 448-453.
41. Hsu YH, Hsieh PP, Chang MS, (2012) Interleukin-19 blockade attenuates collagen-induced arthritis in rats. Rheumatology (Oxford) 51: 434-442.
42. Azuma YT, Matsuo Y, Kuwamura M, Yancopoulos GD, Valenzuela DM, et al. (2010) Interleukin-19 protects mice from innate-mediated colonic inflammation. Inflamm Bowel Dis 16: 1017-1028.
43. Gabunia K, Jain S, England RN, Autieri MV, (2011) Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility. Am J Physiol Cell Physiol 300: C896-906.